These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31766155)

  • 1. Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit.
    Frimat M; Boudhabhay I; Roumenina LT
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31766155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.
    May O; Merle NS; Grunenwald A; Gnemmi V; Leon J; Payet C; Robe-Rybkine T; Paule R; Delguste F; Satchell SC; Mathieson PW; Hazzan M; Boulanger E; Dimitrov JD; Fremeaux-Bacchi V; Frimat M; Roumenina LT
    Front Immunol; 2018; 9():3008. PubMed ID: 30619356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.
    Vinchi F; Tolosano E
    Oxid Med Cell Longev; 2013; 2013():396527. PubMed ID: 23781294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis.
    Merle NS; Grunenwald A; Figueres ML; Chauvet S; Daugan M; Knockaert S; Robe-Rybkine T; Noe R; May O; Frimat M; Brinkman N; Gentinetta T; Miescher S; Houillier P; Legros V; Gonnet F; Blanc-Brude OP; Rabant M; Daniel R; Dimitrov JD; Roumenina LT
    Front Immunol; 2018; 9():179. PubMed ID: 29545789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
    Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
    Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
    Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-Inflammatory Actions of Red Blood Cell-Derived DAMPs.
    Jeney V
    Exp Suppl; 2018; 108():211-233. PubMed ID: 30536173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage.
    Balla J; Jacob HS; Balla G; Nath K; Eaton JW; Vercellotti GM
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9285-9. PubMed ID: 8415693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic Mechanisms of Hemolysis-Associated Thrombo-Inflammation and Immune Dysregulation.
    Dimitrov JD; Roumenina LT; Perrella G; Rayes J
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1349-1361. PubMed ID: 37317847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.
    Deuel JW; Vallelian F; Schaer CA; Puglia M; Buehler PW; Schaer DJ
    Free Radic Biol Med; 2015 Dec; 89():931-43. PubMed ID: 26475040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload.
    Vinchi F; Gastaldi S; Silengo L; Altruda F; Tolosano E
    Am J Pathol; 2008 Jul; 173(1):289-99. PubMed ID: 18556779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases.
    Vinchi F; De Franceschi L; Ghigo A; Townes T; Cimino J; Silengo L; Hirsch E; Altruda F; Tolosano E
    Circulation; 2013 Mar; 127(12):1317-29. PubMed ID: 23446829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron.
    Pires IS; Berthiaume F; Palmer AF
    Annu Rev Biomed Eng; 2023 Jun; 25():1-21. PubMed ID: 37289555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.
    Graw JA; Yu B; Rezoagli E; Warren HS; Buys ES; Bloch DB; Zapol WM
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1120-H1127. PubMed ID: 28314763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new approach to combat the sepsis including COVID-19 by accelerating detoxification of hemolysis-related DAMPs].
    Ousaka D; Nishibori M
    Nihon Yakurigaku Zasshi; 2022; 157(6):422-425. PubMed ID: 36328552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.
    Merle NS; Paule R; Leon J; Daugan M; Robe-Rybkine T; Poillerat V; Torset C; Frémeaux-Bacchi V; Dimitrov JD; Roumenina LT
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6280-6285. PubMed ID: 30850533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics.
    Vallelian F; Buehler PW; Schaer DJ
    Blood; 2022 Oct; 140(17):1837-1844. PubMed ID: 35660854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
    Quimby KR; Hambleton IR; Landis RC
    Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cells, hemoglobin, heme, iron, and atherogenesis.
    Nagy E; Eaton JW; Jeney V; Soares MP; Varga Z; Galajda Z; Szentmiklósi J; Méhes G; Csonka T; Smith A; Vercellotti GM; Balla G; Balla J
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1347-53. PubMed ID: 20378845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell DAMPs and inflammation.
    Mendonça R; Silveira AA; Conran N
    Inflamm Res; 2016 Sep; 65(9):665-78. PubMed ID: 27251171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.